Mega Soft Patient Return Electrode for use during monopolar electrosurgery (MTG11)
Evidence-based recommendations on the Mega Soft Patient Return Electrode for use during monopolar electrosurgery
Search results
202 results
-
-
EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing (MTG12)
Evidence-based recommendations on EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing
-
WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension (MTG13)
Evidence-based recommendations on the WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension
-
Ambu aScope4 Broncho for use in unexpected difficult airways (MTG14)
Evidence-based recommendations on the Ambu aScope4 Broncho for use in unexpected difficult airways
-
The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)
Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds
-
Memokath-051 stent for ureteric obstruction (MTG35)
Evidence-based recommendations on Memokath-051 stent for treating ureteric obstruction
-
Peristeen transanal irrigation system for managing bowel dysfunction (MTG36)
Evidence-based recommendations on the Peristeen transanal irrigation system for people with bowel dysfunction
-
Thopaz+ portable digital system for managing chest drains (MTG37)
Evidence-based recommendations on Thopaz+ for managing chest drains
-
Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)
Evidence-based recommendations on Neuropad for detecting preclinical diabetic peripheral neuropathy
-
iFuse for treating chronic sacroiliac joint pain (MTG39)
Evidence-based recommendations on iFuse for treating chronic sacroiliac joint pain
-
The geko device for reducing the risk of venous thromboembolism (MTG19)
Evidence-based recommendations on the geko device for reducing the risk of venous thromboembolism
-
moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment (MTG2)
Evidence-based recommendations on moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment
-
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers (MTG20)
Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers
-
Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers (MTG40)
Evidence-based recommendations on Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers
-
Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain (MTG41)
Evidence-based recommendations on the Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain
-
UrgoStart for treating diabetic foot ulcers and leg ulcers (MTG42)
Evidence-based recommendations on UrgoStart for treating diabetic foot ulcers and leg ulcers
-
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy (MTG22)
Evidence-based recommendations on VibraTip for testing vibration perception to detect diabetic peripheral neuropathy
-
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters (MTG24)
Evidence-based recommendations on The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters
-
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)
Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C
-
Spectra Optia for automatic red blood cell exchange in people with sickle cell disease (MTG28)
Evidence-based recommendations on Spectra Optia for automated red blood cell exchange in people with sickle cell disease
-
GreenLight XPS for treating benign prostatic hyperplasia (MTG29)
Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia
-
XprESS multi sinus dilation system for treating chronic sinusitis (MTG30)
Evidence-based recommendations on the XprESS multi-sinus dilation system for treating chronic sinusitis after medical treatment has failed
-
Tegaderm CHG securement dressing for vascular access sites in critically ill adults (MTG25)
Evidence-based recommendations on The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites
-
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26)
Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia
-
MT507 Plus Sutures for preventing surgical site infection (MIB204)
In development [GID-MT558] Expected publication date: 09 November 2021
-
3C Patch System for treating diabetic foot ulcers (MT539)
In development [GID-MT559] Expected publication date: 19 January 2022
-
Danis Stent for acute oesophageal variceal bleeds (MT450)
In development [GID-MT537] Expected publication date: 25 May 2021
-
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (MTG16)
Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta
-
The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injury (MTG21)
Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury
-
Xpert MTB/RIF assay for the detection of active pulmonary tuberculosis and multi-drug resistant tuberculosis
In development [GID-DT9] Expected publication date: TBC
-
KRAS mutation testing of tumours in adults with metastatic colorectal cancer (discontinued)
In development [GID-DT14] Expected publication date: TBC
-
Multiple myeloma and related disorders - Freelite assays (and alternative technologies identified during scoping) for diagnosis in primary care
In development [GID-DT28] Expected publication date: TBC
-
Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays) (DG15)
This guidance has been updated and replaced by NICE diagnostics guidance 40.
-
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia (DG2)
Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.
-
Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index (DG17)
This guideline has been updated and replaced by NICE guideline NG131.
-
Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat (DG10)
This guidance has been updated and replaced by NICE diagnostics guidance 34.
-
Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System (DG4)
This guidance has been updated and replaced by NICE diagnostics guidance 32.
-
Levitronix CentriMag for treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency (discontinued)
In development [GID-MT130] Expected publication date: TBC
-
Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease (discontinued)
In development [GID-MT163] Expected publication date: TBC
-
Microthane implants for breast reconstruction or breast augmentation (discontinued)
In development [GID-MT267] Expected publication date: TBC
-
SILK artery reconstruction device (discontinued)
In development [GID-MT81] Expected publication date: TBC
-
SeQuent Please Neo balloon catheter for in-stent coronary restenosis - update of MTG1 (discontinued)
In development [GID-MT516] Expected publication date: TBC
-
OraQuick® HCV Rapid Antibody Test (discontinued)
In development [GID-MT117] Expected publication date: TBC
-
Inditherm patient warming mattress for the prevention of inadvertent hypothermia (MTG7)
In March 2018, NICE reviewed this guidance and recommended it should be withdrawn as it has been updated and replaced by the NICE guideline on hypothermia: prevention and management in adults having surgery. For a copy of the review decision please contact nice@nice.org.uk.
-
BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain (MTG4)
In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.
-
The Assurance Nasal Alar SpO2 Sensor (discontinued)
In development [GID-MT510] Expected publication date: TBC
-
The IN.PACT drug-coated balloon for peripheral arterial disease (CANCELLED)
In development [GID-MT517] Expected publication date: TBC
-
DHT pilot: DECODE decision support system for the identification of dementia (Discontinued)
In development [GID-MT536] Expected publication date: TBC
-
The MAGEC system for spinal lengthening in children with scoliosis (MTG18)
April 2020: This guidance has been withdrawn while the MHRA conducts an investigation into the MAGEC system. The MHRA issued a Medical Device Alert MDA/2020/011 for all MAGEC systems. This is in response to the manufacturer’s latest Field Safety Notice and previous field safety notices for problems that may require early removal of devices and lead to inadequate treatment. The MHRA is not recommending prophylactic removal of devices but the supply of all MAGEC systems is suspended in the UK while the MHRA investigation is ongoing. The MHRA has set out the following actions: Do not implant MAGEC rods in the UK until further notice. Identify all patients implanted with a MAGEC System and ensure systems are in place to follow up these patients.
-
CardioQ-ODM oesophageal doppler monitor (MTG3)
This medical technologies guidance has been replaced by the recommendation on cardiac output monitoring in the NICE guideline on perioperative care in adults.